Parmax Pharma Open Offer Commences July 29, 2026

Parmax Pharma will see an open offer for 23,46,250 shares, representing 26.00% of its expanded voting capital.

Reader Takeaway: Opens tender window for public shareholders; signifies regulatory-driven ownership change.

What just happened

Parmax Pharma Limited has officially launched its open offer to acquire up to 23,46,250 equity shares, which amounts to 26.00% of the company's expanded voting capital. This offer is being extended to public shareholders by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with their Persons Acting in Concert (PACs).

Why this matters

This open offer is a significant event for Parmax Pharma's public shareholders. It provides them with an opportunity to sell their shares at a price determined by the offer. The completion of this offer will lead to a change in the company's shareholding structure and potentially its control.

The backstory

The open offer is a regulatory compliance triggered by the acquisition agreement between the identified acquirers and the company. Such offers are mandated to ensure fair treatment of public shareholders when a change in control or significant stake acquisition occurs.

What changes now

From July 29, 2026, public shareholders can choose to tender their shares in the open offer. The offer will remain open until August 12, 2026. Following the closure, payments are scheduled by August 27, 2026, with a final announcement by September 3, 2026.

Risks to watch

Shareholders need to evaluate the offer price against market value and their investment goals. The actual percentage of shares accepted will depend on the number of shareholders who tender their shares.

Peer comparison

Open offers are common regulatory events in the pharmaceutical sector during M&A activities or stake acquisitions. The terms are specific to each transaction.

Context metrics (time-bound)

The tendering period for the open offer runs from July 29, 2026, to August 12, 2026. Payment to shareholders is expected by August 27, 2026.